62,95 €*
Versandkostenfrei per Post / DHL
Lieferzeit 4-7 Werktage
Contents
SECTION 1
INTRODUCTION AND BACKGROUND
1. The development of the pharmaceutical industry
H P Rang
2. The nature of disease and the purpose of therapy
H P Rang, R G Hill
3. Therapeutic modalities
H P Rang, H LeVine, R G Hill
SECTION 2
DRUG DISCOVERY
4. The drug discovery process: general principles and some case histories
H P Rang, R G Hill
5. Choosing the project
H P Rang, R G Hill
6. Choosing the target
H P Rang, R G Hill
7. The role of information, bioinformatics and genomics
B Robson, R McBurney
8. High-throughput screening
D Cronk
9. The role of medicinal chemistry in the drug discovery process
P Beswick, A Naylor
10. DMPK optimization strategy in drug discovery
P G Ballard, P Brassil, K H Bui, H Dolgos, C Petersson, A Tunek, P J H Webborn
11. Pharmacology: its role in drug discovery
H P Rang
12. Biopharmaceuticals
H LeVine
13. Scaffolds: Small globular proteins as antibody substitutes
D Grabulovski, J Bertschinger
SECTION 3
DRUG DEVELOPMENT
14. Drug development: introduction
H P Rang, R G Hill
15. Assessing drug safety
H P Rang, R G Hill
16. Pharmaceutical developmentT Lundqvist, S Bredenberg
17. Clinical Development - Present and Future
C Keywood
18. Clinical imaging in drug development
P M Matthews
19. Intellectual property in drug discovery and development
P Grubb
20. Regulatory affairs
I Hägglöf, Å Holmgren
21. Marketing the drug
V L Lawton
SECTION 4
FACTS AND FIGURES
22. Drug discovery and development - facts and figures
H P Rang, R G Hill
Fachbereich: | Toxikologie |
---|---|
Genre: | Medizin |
Rubrik: | Wissenschaften |
Medium: | Taschenbuch |
ISBN-13: | 9780702042997 |
ISBN-10: | 0702042994 |
Sprache: | Englisch |
Redaktion: | Hill, Raymond G |
Auflage: | 2nd ed. |
Hersteller: | Churchill Livingstone |
Verantwortliche Person für die EU: | preigu, Ansas Meyer, Lengericher Landstr. 19, D-49078 Osnabrück, mail@preigu.de |
Abbildungen: | w. ill. |
Maße: | 17 x 189 x 246 mm |
Von/Mit: | Raymond G Hill |
Gewicht: | 0,784 kg |
Contents
SECTION 1
INTRODUCTION AND BACKGROUND
1. The development of the pharmaceutical industry
H P Rang
2. The nature of disease and the purpose of therapy
H P Rang, R G Hill
3. Therapeutic modalities
H P Rang, H LeVine, R G Hill
SECTION 2
DRUG DISCOVERY
4. The drug discovery process: general principles and some case histories
H P Rang, R G Hill
5. Choosing the project
H P Rang, R G Hill
6. Choosing the target
H P Rang, R G Hill
7. The role of information, bioinformatics and genomics
B Robson, R McBurney
8. High-throughput screening
D Cronk
9. The role of medicinal chemistry in the drug discovery process
P Beswick, A Naylor
10. DMPK optimization strategy in drug discovery
P G Ballard, P Brassil, K H Bui, H Dolgos, C Petersson, A Tunek, P J H Webborn
11. Pharmacology: its role in drug discovery
H P Rang
12. Biopharmaceuticals
H LeVine
13. Scaffolds: Small globular proteins as antibody substitutes
D Grabulovski, J Bertschinger
SECTION 3
DRUG DEVELOPMENT
14. Drug development: introduction
H P Rang, R G Hill
15. Assessing drug safety
H P Rang, R G Hill
16. Pharmaceutical developmentT Lundqvist, S Bredenberg
17. Clinical Development - Present and Future
C Keywood
18. Clinical imaging in drug development
P M Matthews
19. Intellectual property in drug discovery and development
P Grubb
20. Regulatory affairs
I Hägglöf, Å Holmgren
21. Marketing the drug
V L Lawton
SECTION 4
FACTS AND FIGURES
22. Drug discovery and development - facts and figures
H P Rang, R G Hill
Fachbereich: | Toxikologie |
---|---|
Genre: | Medizin |
Rubrik: | Wissenschaften |
Medium: | Taschenbuch |
ISBN-13: | 9780702042997 |
ISBN-10: | 0702042994 |
Sprache: | Englisch |
Redaktion: | Hill, Raymond G |
Auflage: | 2nd ed. |
Hersteller: | Churchill Livingstone |
Verantwortliche Person für die EU: | preigu, Ansas Meyer, Lengericher Landstr. 19, D-49078 Osnabrück, mail@preigu.de |
Abbildungen: | w. ill. |
Maße: | 17 x 189 x 246 mm |
Von/Mit: | Raymond G Hill |
Gewicht: | 0,784 kg |